Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk-Reference-Cited by-同舟云学术

Factor VII –323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

Published:2008-01 Issue:7 Volume:40 Page:553-559
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Roldán Vanessa,Marín Francisco,González-Conejero Rocío,García-Honrubia Antonio,Martí Silvia,Alfaro Aranzazu,Valdés Mariano,Corral Javier,Lip Gregory Y. H.,Vicente Vicente

Publisher

Informa UK Limited

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/07853890802108412

Reference36 articles.

1. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

2. Does atrial fibrillation confer a hypercoagulable state?

3. Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial Fibrillation

4. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

5. Genetic Polymorphisms and Thromoembolic Risk in Atrial Fibrillation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Glycoprotein IIIa PlA1/A2 Polymorphism with Risk of Stroke: Updated Meta-Analysis;Current Issues in Molecular Biology;2024-05-28

2. Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis;Haematologica;2021-01-07

3. Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response;Expert Review of Precision Medicine and Drug Development;2020-09-02

4. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update;EuroIntervention;2020-01

5. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update;EP Europace;2019-08-31